chad63-kh
Vaccineexperimental
Clinical trial activity
2 trials · 2 clinical orgs · 0 marketing orgs
Phase 1
0
Phase 2
2
Phase 3
0
Phase 4
0
Earliest trial started Aug 31, 2019 (NCT03969134)
Timeline
2010s
- Jan 1, 2019
Earliest Phase 2 Sponsor(trial)
Indications
Studied for
Mechanism of action
- LeishmaniaImmunity, active
Leishmania immunity, active
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT04107961 | Phase 2 | Jan 31, 2020 | University of York, Wellcome Trust |
| NCT03969134 | Phase 2 | Aug 31, 2019 | University of York |
Showing 2 of 2 trials
Page 1 / 1
Organizations
Research & Development (2)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| University of York | Academic/Hospital | 2 | 2 | 1 | 2019 |
| Wellcome Trust | Academic/Hospital | 1 | 0 | 1 | 2020 |
2 organizations
Page 1 / 1